Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "022115."
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
25MG |
| Application Number: |
N022115 |
| Product Number: |
001 |
| Approval Date: |
May 29, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
50MG |
| Application Number: |
N022115 |
| Product Number: |
002 |
| Approval Date: |
May 29, 2009 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
100MG |
| Application Number: |
N022115 |
| Product Number: |
003 |
| Approval Date: |
May 29, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
200MG |
| Application Number: |
N022115 |
| Product Number: |
004 |
| Approval Date: |
May 29, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
300MG |
| Application Number: |
N022115 |
| Product Number: |
005 |
| Approval Date: |
Apr 14, 2010 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
LAMOTRIGINE |
| Dosage Form;Route: |
TABLET, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
LAMICTAL XR |
| Applicant: |
GLAXOSMITHKLINE LLC |
| Strength: |
250MG |
| Application Number: |
N022115 |
| Product Number: |
006 |
| Approval Date: |
Jun 21, 2011 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB |
| Patent and Exclusivity Info for this product: |
View |
|
Return to Electronic Orange Book Home Page
|
FDA/Center for Drug Evaluation and Research
|
|
Office of Generic Drugs
|
|
Division of Labeling and Program Support
|
|
Update Frequency: |
|
Orange Book Data - Monthly
|
|
Generic Drug Product Information & Patent Information - Daily
|
|
Orange Book Data Updated Through April, 2013
|
|
Patent and Generic Drug Product Data Last Updated: May 24, 2013
|
-
